In summary, HIF inhibitors and PHD activity regulate the hypoxic response pathway by directly or indirectly regulating HIF gene expression, and have the potential to improve the hypoxic microenvironment and treat RA and other related diseases. Here, PDC is linked to rheumatoid arthritis.